A next generation, high capacity protein A chromatography resin for advanced protein separation in downstream processing.
Amsphere A3 is a next generation Protein A chromatography resin for advanced protein separation in downstream processing of therapeutic antibodies manufacturing.
Besides an outstanding high capacity, Amsphere A3 has an overall improved process robustness, flow characteristics, optimized impurity removal, productivity and resin lifetime.
Companies will work together on critical componentsthat canaccelerateclient-sponsored validation programs through downstream drug development
FREMONT, Calif. and DURHAM, N.C. –October 11, 2021–Eurofins DiscoverX Products,LLC(Eurofins DiscoverX),an industryleader in assays for drug...
Platform combining phenotypic high content imaging analysis and three-dimensional models of fresh patient tumors to provide relevant analysis of drug responses that can inform candidate selection and clinical program design
SUNNYVALE, California, October 7, 2021 – Crown Bioscience, a JSR Life...
Tokyo, Japan - September 30, 2021 - Medical & Biological Laboratories Co., Ltd. (MBL), a JSR Life Sciences Company, has signed a distributor agreement with Qkine Ltd. for sale of products in Japan.
In recent years, there has been an increasing need for reagents that meet the high biological raw...
Extending the lifetime of Protein A resin during the downstream process of manufacturing a biomolecule can have significant positive effects on your process economy. In this webinar, NaOH in combination with ethylene glycol, ethanol, IPA, and thioglycerol are examined. Bacterial challenge, soaking, and life cycle data on Amsphere A3 resin using PAA will be presented.